Neogenix Oncology, Inc.'s Novel Antibody NEO-101 Named One of Windhover Information Inc.'s Top 10 Projects to Watch
11/30/2011 8:55:38 AM
More...
|
Neogenix Oncology, Inc. and Cambridge Biomedical Inc. Form a Partnership for Development of Blood Based Cancer Diagnostic Tests
6/16/2011 8:57:02 AM
More...
|
Neogenix Oncology, Inc. Announces Enhancement of Management Consulting Team
6/14/2011 9:33:53 AM
More...
|
Data on Neogenix Oncology, Inc.’s Phase I Study of Novel Therapeutic Antibody NPC-1C (Ensituximab) to be Presented at American Society of Clinical Oncology’s 2011 Annual Meeting
6/3/2011 8:10:00 AM
More...
|
Neogenix Oncology, Inc. Obtains Patent in Europe Relating to Its NEO-301 Antibody
5/12/2011 11:08:00 AM
More...
|
Neogenix Oncology, Inc. to Hold Conference Call to Discuss 2010 Financial Results and Company Highlights
4/7/2011 9:23:14 AM
More...
|
Neogenix Oncology, Inc. Hires Dr. Albine Martin as Chief Operating Officer
2/17/2011 10:38:08 AM
More...
|
Neogenix Oncology, Inc. Will Present Data on a New Stool Biomarker Test for the Detection of Colorectal Cancer at American Society of Clinical Oncology's 2011 Gastrointestinal Cancers Symposium
1/19/2011 10:39:33 AM
More...
|
Selexis SA and Neogenix Oncology, Inc. Execute Commercial License Agreement
1/12/2011 11:05:25 AM
More...
|
Neogenix Oncology, Inc. Receives Additional Federal Grant, Bringing Total Award to Over $730,000
1/6/2011 11:04:55 AM
More...
|
|